Synthesis of oligotuftsin-based branched oligopeptide conjugates for chemotactic drug targeting

Journal of Peptide Science

Volumn 12, Issue 5, 2006, Pages 328-336

  Mezö, Gábor ^a   Láng, Orsolya ^b   Jakab, Annamária ^a   Bai, Katalin B ^a   Szabó, Ildikó ^a   Schlosser, Gitta ^a   Láng, Julianna ^b   Köhidai, László ^b   Hudecz, Ferenc ^a,c  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Chemotactic peptide; Chemotaxis; Conjugation; Cytotoxicity; Drug targeting; Methotrexate; Tetratuftsin; Thioether linkage

Indexed keywords

CATHEPSIN B; CHEMOTACTIC PEPTIDE; METHOTREXATE; OLIGOPEPTIDE; TUFTSIN DERIVATIVE;

ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SOLID PHASE SYNTHESIS; TETRAHYMENA PYRIFORMIS;

AMINO ACID SEQUENCE; ANIMALS; CHEMOTACTIC FACTORS; CHEMOTAXIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FOLIC ACID ANTAGONISTS; METHOTREXATE; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TETRAHYMENA PYRIFORMIS; TUFTSIN;

TETRAHYMENA PYRIFORMIS;

EID: 33646400608     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.729     Document Type: Article

References (28)

1. Hudecz F, Reményi J, Szabó R, Kóczán G, Mezo G, Kovács P, Gaál D. Drug targeting by macromolecules without recognition unit? J. Inclusion Phenom. Mol. Recognit. Chem. 2003; 16: 288-298.
2. Schiffman E, Corcoran BA, Wahl SM. Formyl methionyl peptides as chemoattractants for leukocytes. Proc. Natl. Acad. Sci. U.S.A. 1975; 72: 1059-1062.
3. Showell HJ, Freer RJ, Zigmond SH, Schiffman E, Aswanikumar S, Corcoran BA, Becker EL. The structure-activity relations of the synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion of neutrophils. J. Exp. Med. 1976; 143: 1154-1169.
4. Becker EL. The formyl peptide receptor of the neutrophil. A search and conserve operation. Am. J. Pathol. 1987; 129: 16-24.
5. Freer RJ, Day AR, Radding E, Schiffman E, Aswanikumar S, Showell HJ, Becker EL. Further studies on the structural requirement for synthetic peptide chemoattractant. Biochemistry 1980; 19: 2404-2410.
6. αα-dialkylated glycine at position 2. Pept. Res. 1989; 2: 275-281.
7. Schiffman E, Aswanikumar S, Venkatasubramanian K, Corcoran BA, Pert CB, Brown J, Gross E, Day AR, Freer RJ, Showell HJ, Becker EL. Some characteristics of the neutrophil receptor for chemotactic peptides. FEBS Lett. 1980; 117: 1-7.
8. Fruchtmann R, Kreisfeld K, Marowski C, Opitz W. Synthetische tripeptide als chemotaxine bzw. Chemotaxinantagonisten. Hoppe-Seyler's Z. Physiol. Chem. 1981; 362: 163-174.
9. Mezo G, Kalászi A, Reményi J, Majer Zs, Hilbert A, Láng O, Kohidai L, Barna K, Gaál D, Hudecz F. Synthesis, conformation, and immunoreactivity of new carrier molecules based on repeated tuftsin-like sequence. Biopolymers 2004; 73: 645-656.
10. Mezo G, de Oliveira E, Krikorian D, Feijlbrief M, Jakab A, Tsikaris V, Sakarellos C, Welling-Wester S, Andreu D, Hudecz F. Synthesis and comparison of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope VII. Bioconjug. Chem. 2003; 14: 1260-1269.
11. Mezo G, Manea M, Jakab M, Kapuvári B, Bosze Sz, Schlosser G, Przybylski M, Hudecz F. Synthesis and structural characterisation of bioactive peptide conjugates using thioether linkage approaches. J. Pept. Sci. 2004; 10: 701-713.
12. Manea M, Hudecz F, Przybylski M, Mezo G. Synthesis, solution conformation and antibody recognition of oligotuftsin based conjugates containing a β-amyloid(4-10) plaques specific epitope. Binconjug. Chem. 2005; 16: 921-928.
13. Farber S, Diamond LK, Mercer RD, Sylvester RF, Wolff JA. Temporary remissions in acute leukemia in children produced by folic acid antagonists, 4-aminopteroylglutamic acid, (aminopterin). N. Engl. J. Med. 1948; 238: 787-793.
14. Bleyer WA, Drake JC, Chabner BA. Neurotoxicity and elevated cerebrospinal - fluid methotrexate concentration in meningeal leukaemia. N. Engl. J. Med. 1973; 289: 770-773.
15. Furst DE, Kremer JM. Methotrexate in rheumatoid arthritis. Arthritis Rheum 1988; 31: 305-314.
16. Gardner-Medwin JM, Powell RJ. One patient, two unusual conditions and three basic lessons. Ann. Rheum. Dis. 1996; 55: 350-352.
17. Mukhopadhyay A, Chaudhuri G, Arora SK, Sehgal S, Basu SK. Receptor mediated drug delivery to macrophages in chemotherapy of leishmaniasis. Science 1989; 244: 705-707.
18. Kóczán G, Ghose AC, Mookerjee A, Hudecz F. Methotrexate conjugate with branched polypeptide influences Leishmania donovani infection in vitro and in experimental animals. Bioconjug. Chem. 2002; 13: 518-524.
19. Omelyanenko V, Gentry C, Kopeckova P, Kopecek J. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro. Int. J. Cancer 1998; 75: 600-608.
20. Christopher GK, Sundermann CA. Isolation and partial characterization of the insulin binding sites of Tetrahymena pyriformis. Biochem. Biophys. Res. Commun. 1995; 212: 515-523.
21. Csaba G. Phylogeny and ontogeny of chemical signalling: Origin and development of hormone receptors. Int. Rev. Cytol. 1994; 155: 1-47.
22. Martinez J, Laur J. Active esters of formic acid as useful formylating agents: improvements in the synthesis of formyl-amino acid esters, N-α-Formyl-Met-Leu-Phe-OH, and Formyl-Met-Lys-Pro-Arg, a phagocytosis stimulating peptide. Synthesis 1982; 979-981.
23. Ivanov BB, Robey FA. Effective use of free thiols as scavengers for HF cocktails to deprotect bromo- and chloroacetylated synthetic peptides. Pept. Res. 1996; 9: 305-307.
24. Leick V, Helle J. A quantitative assay for ciliate chemotaxis. Anal. Biochem. 1983; 135: 466-469.
25. Kohidai L, Lemberkovits E, Csaba G. Molecule dependent chemotactic responses of Tetrahymena pyriformis elicited by volatile oils. Acta Protozool. 1995; 34: 181-185.
26. Kohidai L, Schiess N, Csaba G. Chemotactic selection of Tetrahymena pyriformis GL induced with histamine, diiodotyrosine or insulin. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2000; 126: 1-9.
27. Subr V, Strohalm J, Hirano T, Ito Y, Ulbrich K. Poly[N-(2-hydroxypropyl)methacrylamide] conjugates of methotrexate. Synthesis and in vitro drug release. J. Controlled Release 1997; 49: 123-132.
28. Evans WE, Crom WR, Abromowitch M, Dodge R, Look AT, Bowman WP, George SL, Pui CH. Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect. N. Engl. J. Med. 1986; 314: 471-477.